Skip to main content

Table 1 Adult-onset patients

From: The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients

Patient ID

Onset, diagnosis (Age; y)

ERT start (Age; y)

Biopsy site; time on ERT (y)

Pathology/% fibers with lipofuscin inclusions

Clinical status (Current age)

D4

27, 39

61

Forearm; 5-6

Mild lysosomal expansion in 2-4% of fibers; autophagic accumulation and inclusions in < 5% of fibers

Decreased strength; relies on wheelchair; can take a few steps (67 y)

D7

35, 61

62

VL; pre-treatment

Moderate lysosomal expansion in most fibers; autophagic accumulation and inclusions in ~33% of fibers

Relies on BIPAP at night; limited capacity for physical activity; independently ambulatory (62 y)

D8

35, 47

52

VL; 6*

Mild lysosomal expansion; autophagic accumulation and inclusions in ~42% of fibers

Relies on BiPAP; difficulty with stairs and getting out of the car and off the floor; relies on walker (58 y)

D9

10, 35

41

VL; 6-7

Mild-to-moderate lysosomal expansion in almost every fiber; autophagic accumulation in ~44% of fibers (20% with inclusions)

CPAP for sleep apnea; ambulatory with cane and walker (48 y)

D10

51 or 52, 54

54

VL; 5

Autophagic accumulation in ~19% of fibers; ~5% of fibers are destroyed**; inclusions are in <1% of fibers

Ambulatory with cane; difficulty with stairs and getting out of the car and off the floor (59 y)

D12

48, 62

63

VL; 2

Mild lysosomal expansion; most fibers are normal; autophagic accumulation and inclusions are in < 5% of fibers

Uses BiPAP at night; ambulatory (65 y)

D13

43, 43

46

VL; 2

Normal biopsy

Trunk weakness, lower back pain; ambulatory (48 y)

D14

51, 52

57

VL; 5

Moderate lysosomal expansion; autophagic accumulation and inclusions in ~30% of fibers

Uses walker periodically (62 y)

D15

22, 41

N/A

VL; 7

Mild-to-moderate lysosomal expansion; autophagic accumulation in ~46% of fibers (14% with inclusions)

Proximal weakness in upper and lower limbs; ambulatory with cane; relies on BiPAP; severe respiratory insufficiency (49 y)

D16

mid teens, 17

28

VL; 7

Mild lysosomal expansion; autophagic accumulation in ~16% of fibers; inclusions are in < 5% of fibers

Proximal weakness in upper and lower limbs; uses BiPAP at night; falls; difficulty climbing stairs (35 y)

D17

late 20s, 55

55

VL; 4

Autophagic accumulation with inclusions in ~20% of fibers

Proximal weakness in upper and lower limbs; ambulatory with cane or scooter; relies on BiPAP (59 y)

D19

39, 45

56

VL; 5

Autophagic accumulation with inclusions in ~25% of fibers

Weakness of the hip extensors and hip abductors; independently ambulatory; difficulty getting up from supine position (61 y)

  1. *Increased dose to 30 mg/kg since 12/2011.
  2. D12 and D13 are siblings and D8 and D9 are siblings.
  3. Vastus Lateralis.
  4. **the fibers lacking recognizable myofibrillar structures are classified as “destroyed”.